Hizentra (human immune globulin subcutaneous 20%) / CSL Behring  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hizentra (human immune globulin subcutaneous 20%) / CSL Behring
NCT05584631: IVIG vs SCIG in CIDP

Recruiting
1
20
US
Intravenous immune globulin G, Privigen, IVIG, Subcutaneous immune globulin G, Hizentra, SCIG
Rutgers, The State University of New Jersey
CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy
10/24
10/24

Download Options